The Safety of Direct Oral Anticoagulants Versus Warfarin Among Older Individuals With Acute Venous Thromboembolism and CKD: A Population-Based Cohort Study
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Ha J, Neuen B, Cheng L, Jun M, Toyama T, Gallagher M
. Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis. Ann Intern Med. 2019; 171(3):181-189.
DOI: 10.7326/M19-0087.
View
2.
Molnar A, Bota S, McArthur E, Lam N, Garg A, Wald R
. Risk and complications of venous thromboembolism in dialysis patients. Nephrol Dial Transplant. 2017; 33(5):874-880.
DOI: 10.1093/ndt/gfx212.
View
3.
Harel Z, Mamdani M, Juurlink D, Garg A, Wald R, Yao Z
. Novel Oral Anticoagulants and the Risk of Major Hemorrhage in Elderly Patients With Chronic Kidney Disease: A Nested Case-Control Study. Can J Cardiol. 2016; 32(8):986.e17-22.
DOI: 10.1016/j.cjca.2016.01.013.
View
4.
Ribic C, Crowther M
. Thrombosis and anticoagulation in the setting of renal or liver disease. Hematology Am Soc Hematol Educ Program. 2016; 2016(1):188-195.
PMC: 6142494.
DOI: 10.1182/asheducation-2016.1.188.
View
5.
Harel Z, Sholzberg M, Shah P, Pavenski K, Harel S, Wald R
. Comparisons between novel oral anticoagulants and vitamin K antagonists in patients with CKD. J Am Soc Nephrol. 2014; 25(3):431-42.
PMC: 3935586.
DOI: 10.1681/ASN.2013040361.
View